Adverse effects associated with dexamethasone, lorazepam, and granisetron.
M B
MB
Kaufman
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D003907:Dexamethasone / Q000009:adverse effects*; D005260:Female; D005483:Flushing / Q000139:chemically induced; D017829:Granisetron / Q000009:adverse effects*; D006258:Head and Neck Neoplasms / Q000188:drug therapy; D006801:Humans; D006940:Hyperemia / Q000139:chemically induced; D007262:Infusions, Intravenous; D008140:Lorazepam / Q000009:adverse effects*
D003907:Dexamethasone; D017829:Granisetron; D008140:Lorazepam